This webinar is to inform and educate interventional cardiologists and cardiac surgeons on:
Epidemiology of atrial fibrillation and stroke risk
Left atrial appendage closure: surgical and percutaneous approaches
Randomized controlled trial data with WATCHMAN
Percutaneous devices for LAA closure
Safety and efficacy of LAA closure
Key references:
Saw J, Lempereur M. Percutaneous Left Atrial Appendage Closure: Procedural Techniques and Outcomes. JACC Cardiovasc Interv 2014;7(11):1205-1220.
Price, MA, Valderrabano. Left Atrial Appendage Closure to prevent strokes in Patients With Atrial Fibrillation. Circulation. 2014;130:202-212.
Holmes DR, Reddy VY, Turi ZG, et al., for the PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534–42.
Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 2014;64:1–12.
